021-51111890
购物车（0）
sales@molnova.cn
Icatibant Acetate
CAS No. 138614-30-9
Icatibant Acetate ( —— )
产品货号. M23545 CAS No. 138614-30-9
Icatibant Acetate 是一种缓激肽 B2 受体拮抗剂，用于治疗遗传性血管性水肿。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥794 | 有现货 |
|
| 5MG | ￥1596 | 有现货 |
|
| 10MG | ￥2535 | 有现货 |
|
| 25MG | ￥4277 | 有现货 |
|
| 50MG | ￥6099 | 有现货 |
|
| 100MG | ￥7995 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Icatibant Acetate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Icatibant Acetate 是一种缓激肽 B2 受体拮抗剂，用于治疗遗传性血管性水肿。
-
产品描述Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema.
-
体外实验——
-
体内实验Animal Model:Female mice of the CBA/J (H-2k) strain.Dosage:0.06, 0.3, or 1.5 mg/kg.Administration:Subcutaneous administration twice daily.Result:The length of the large intestine was 93.6±6.8 mm with the 1.5 mg/kg dosage and 94.0±4.1 mm with the 0.3 mg/kg dosage , showing a significant preventive effect on shortening.
-
同义词——
-
通路GPCR/G Protein
-
靶点Bradykinin Receptor
-
受体bradykinin B2
-
研究领域——
-
适应症——
化学信息
-
CAS Number138614-30-9
-
分子量1364.57
-
分子式C61H93N19O15S
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL?(73.28 mM;?Need ultrasonic)
-
SMILESCC(=O)O.N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC(=O)N[C@@H](Cc3cccs3)C(=O)N[C@@H](CO)C(=O)N4Cc5ccccc5C[C@@H]4C(=O)N6[C@H]7CCCC[C@H]7C[C@H]6C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Charignon D, et al. Expert Opin Pharmacother. 2012, 13(15):2233-47.
产品手册
关联产品
-
Lys-[Des-Arg9]Bradyk...
Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.
-
B-Raf IN 14
B-Raf IN 14（Comp 25）是一种 BRAF?抑制剂，其 IC50 值为 11.08 μM，可用于癌症相关研究。
-
[Phe8Ψ(CH-NH)-Arg9]-...
Selective bradykinin B2 receptor agonist that is resistant to carboxypeptidase cleavage. 5-fold more potent and exhibits a more prolonged duration of action than bradykinin in vivo.
